Alpha-MSH
low riskAlso: α-Melanocyte Stimulating Hormone · ACTH(1-13) · Melanotropin
Alpha-MSH is an endogenous melanocortin peptide from the pro-opiomelanocortin (POMC) precursor. Has broad anti-inflammatory properties, regulates skin pigmentation, suppresses appetite via MC4R, and provides neuroprotection. Precursor to Melanotan I and II pharmacology.
Reported Benefits
Anti-inflammatory
Extensive evidence for peripheral and central anti-inflammatory effects; basis for melanocortin anti-inflammatory drug development.
Melanogenesis
Foundational melanocyte biology. MC1R activation drives melanin synthesis — well-characterized.
Mechanism of Action
Endogenous agonist at MC1R (melanogenesis), MC3R (energy balance), MC4R (appetite suppression); activates anti-inflammatory pathways via NF-κB inhibition; reduces TNF-α, IL-6, IL-1β.
The Melanocortin System
Alpha-MSH is the endogenous reference point for the entire melanocortin drug class: Melanotan I (MC1R-selective), Melanotan II (non-selective), PT-141/Bremelanotide (MC3R/MC4R). Understanding α-MSH physiology clarifies why these drugs have their respective profiles.
Regulatory Status
Research OnlySafety Profile
Side Effects
- •Not applicable as endogenous hormone
Contraindications
- •N/A
Primary Uses
Related Peptides
Weekly Briefing
Regulatory updates + new study breakdowns.
For Practitioners
Do you prescribe Alpha-MSH?
Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.
Get Listed →